INTERNATIONAL PATENT: ARVINAS OPERATIONS, INC. FILES APPLICATION FOR "COMPOUNDS FOR THE TARGETED DEGRADATION OF B-CELL LYMPHOMA 6 (BCL6)"

GENEVA, March 19 -- ARVINAS OPERATIONS, INC. (5 Science Park395 Winchester AvenueNew Haven, Connecticut 06511) filed a patent application (PCT/US2025/044984) for "COMPOUNDS FOR THE TARGETED DEGRADATION OF B-CELL LYMPHOMA 6 (BCL6)" on Sep 05, 2025. With publication no. WO/2026/055403, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHERMAN, Dan (103 Colonial RoadMadison, Connecticut 06443)

Abstract: Provided are compounds of the Formula PTM-L-CLM, or a pharmaceutically acceptable salt thereof, wherein the PTM is (PTM-I) T...